US Broker Ratings

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a Promising 16% Upside Potential

GE HealthCare Technologies Inc. (GEHC), a formidable player in the Healthcare sector, continues to command attention with its innovative strides in health information services. The company,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising 36% Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS) stands out in the biotechnology sector with a market capitalization of $4.36 billion, making it a notable contender in the healthcare..

Alnylam Pharmaceuticals Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with Diverse Pipeline and High Valuation

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, boasting a market capitalization of $59.56 billion. Known for pioneering therapeutics based..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech Contender with 52% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical firm, is currently making waves in the biotechnology sector. With a market capitalization of $5.49 billion, Nuvalent is focused..

Fresenius Medical Care AG (FMS) Investor Outlook: Navigating a 20.78% Upside Potential in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, stands poised for potential growth within the medical care facilities industry. Headquartered in..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Healthcare Diagnostics with a $27.22 Billion Market Cap

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable player within the healthcare sector, specifically in the diagnostics and research industry. With a substantial market capitalization..

Akero Therapeutics (AKRO) Investor Outlook: Analysts See 54.93% Upside Potential

Investors eyeing Akero Therapeutics, Inc. (NASDAQ: AKRO) will find a compelling case for potential growth, driven by the company’s focus on breakthrough treatments for serious metabolic..

Encompass Health (EHC) Stock Analysis: A Promising 10.52% Potential Upside in Healthcare

Encompass Health Corporation (NYSE: EHC), a leader in the healthcare sector focusing on medical care facilities, presents a compelling investment opportunity with a potential upside of..

Veeva Systems Inc. (VEEV) Stock Analysis: A Closer Look at Its 3.41% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a leading provider of cloud-based software solutions tailored specifically for the life sciences industry. With a current market capitalization..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Exploring the 89.39% Return on Equity and Its Impact on Investor Decisions

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has been capturing attention with its impressive..

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 24% Upside Potential in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, is drawing significant investor attention with its robust potential upside of 24.07%. As a key entity..

argenx SE (ARGX) Stock Analysis: Unpacking a 22% Potential Upside in the Biotech Giant

argenx SE (ARGX), a biotechnology powerhouse based in the Netherlands, is capturing investor attention with its impressive growth trajectory and innovative therapeutic portfolio. With a market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Examining 26.60% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a powerhouse in the healthcare sector, particularly in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Revolution Medicines, Inc. (RVMD): Analyzing Nearly 96% Upside Potential in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology firm specializing in precision oncology, is capturing investor attention with a striking potential upside of 95.62%, driven by..

Elevance Health, Inc. (ELV) Stock Analysis: A Promising 16% Upside with Strong Analyst Endorsement

Investors eyeing the healthcare sector may find Elevance Health, Inc. (NYSE: ELV) an enticing prospect, particularly given its substantial market presence and potential upside. With a..

Biogen Inc. (BIIB) Stock Analysis: Exploring the 21.63% Potential Upside

Biogen Inc. (NASDAQ: BIIB), a key player in the healthcare sector, continues to capture the attention of investors with its innovative therapies aimed at treating neurological..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 22.57% Upside Potential in the Healthcare Tech Giant

Intuitive Surgical, Inc. (NASDAQ: ISRG), a vanguard in the medical instruments and supplies industry, remains a pivotal player in the healthcare sector with its cutting-edge technology...

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing the 255.76% Potential Upside in the Biotechnology Sector

Investors eyeing the biotechnology sector have a compelling opportunity to consider in Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company. With a market cap of..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant’s Strategic Position and 14% Upside

McKesson Corporation (NYSE: MCK), a cornerstone of the healthcare sector, continues to capture investor attention with its robust operational framework and promising growth potential. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds